|
According to a new study by FMI, the sales of taurine are expected to be valuated at about $250 million, towards the end of 2019. While gains will be underpinned by a slew of factors, including changing regulatory scenarios, the report suggested that wide applications of taurine, and research and development (R&D) for the launch of innovative products will also contribute significantly to the sales of taurine in the near future.
|